ArticleJournal of oncology2022

Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma.

Shaohua Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.